Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 24, 2015
Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling DonorsScott R Solomon, Connie A Sizemore, Melissa Sanacore, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 7, 2012
Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trialScott R Solomon, Connie A Sizemore, Melissa Sanacore, et al.Advances in Hematology|April 16, 2021
A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic MalignanciesMelhem M Solh, Gabriel Hinojosa, Justin Laporte, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantationAsad Bashey, Xu Zhang, Connie A Sizemore, et al.Blood Advances|August 11, 2020
Prospective phase 2 trial of ixazomib after nonmyeloablative haploidentical peripheral blood stem cell transplantScott R Solomon, Melhem Solh, Xu Zhang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2016
T Cell-Replete HLA Haploidentical Donor Transplantation with Post-Transplant Cyclophosphamide Is an Effective Salvage for Patients Relapsing after an HLA-Matched Related or Matched Unrelated Donor TransplantationJessica Gorgeis, Xu Zhang, Katelin Connor, et al.British Journal of Haematology|August 24, 2005
Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioningAldemar Montero, Bipin N Savani, Roger Kurlander, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2015
Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk IndexAsad Bashey, Xu Zhang, Katelin Jackson, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2005
Improved outcome for peripheral blood stem cell transplantation for advanced primary myelodysplastic syndromeScott R Solomon, Bipin N Savani, Richard Childs, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2015
Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating RituximabScott R Solomon, Connie A Sizemore, Michelle Ridgeway, et al.Pageof 8